Literature DB >> 25691655

Quality of HbA1c Measurement in the Practice: The German Perspective.

Lutz Heinemann1, Guido Freckmann2.   

Abstract

Hemoglobin A1c (HbA1c) measurement has come to be a cornerstone in modern diabetes therapy. However, the methodological aspects of this type of measurement have been given little attention lately due to its position as an established method of choice. Nevertheless, quite a number of issues face practical application, such as clinically relevant differences between different measurement methods--both lab-based and point-of-care (POCT) systems will show better or worse diabetes management results after switching methods; and there are a number of possible reasons that need to be known and observed in practice. The aim of this review is to draw attention to these problems from a German point of view and provide suggestions for appropriate measures to improve the situation.
© 2015 Diabetes Technology Society.

Entities:  

Keywords:  HbA1c; National Glycohemoglobin Standardization Program; laboratory determination; point-of-care testing instruments

Mesh:

Substances:

Year:  2015        PMID: 25691655      PMCID: PMC4604529          DOI: 10.1177/1932296815572254

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  16 in total

Review 1.  Development of a reference system for the international standardization of HbA1c/glycohemoglobin determinations.

Authors:  W Hoelzel; K Miedema
Journal:  J Int Fed Clin Chem       Date:  1996-06

2.  Point: The reporting of estimated glucose with hemoglobin A1c.

Authors:  David B Sacks; Richard M Bergenstal; Susan McLaughlin
Journal:  Clin Chem       Date:  2010-02-18       Impact factor: 8.327

3.  Multicentre evaluation of the Tosoh HbA1c G8 analyser.

Authors:  Jean-Paul Chapelle; Jelda Teixeira; Diane Maisin; Hans Assink; Gerhard Barla; An K Stroobants; Barend Delzenne; Wouter van den Eshof
Journal:  Clin Chem Lab Med       Date:  2010-03       Impact factor: 3.694

4.  Three of 7 hemoglobin A1c point-of-care instruments do not meet generally accepted analytical performance criteria.

Authors:  Erna Lenters-Westra; Robbert J Slingerland
Journal:  Clin Chem       Date:  2014-05-27       Impact factor: 8.327

5.  Approved IFCC reference method for the measurement of HbA1c in human blood.

Authors:  Jan-Olof Jeppsson; Uwe Kobold; John Barr; Andreas Finke; Wieland Hoelzel; Tadao Hoshino; Kor Miedema; Andrea Mosca; Pierluigi Mauri; Rita Paroni; Linda Thienpont; Masao Umemoto; Cas Weykamp
Journal:  Clin Chem Lab Med       Date:  2002-01       Impact factor: 3.694

6.  Clinical assessment of the accuracy of blood glucose measurement devices.

Authors:  Andreas Pfützner; Michael Mitri; Petra B Musholt; Daniela Sachsenheimer; Marcus Borchert; Andrew Yap; Thomas Forst
Journal:  Curr Med Res Opin       Date:  2012-03-21       Impact factor: 2.580

7.  System accuracy evaluation of 27 blood glucose monitoring systems according to DIN EN ISO 15197.

Authors:  Guido Freckmann; Annette Baumstark; Nina Jendrike; Eva Zschornack; Serge Kocher; Jacques Tshiananga; Frank Heister; Cornelia Haug
Journal:  Diabetes Technol Ther       Date:  2010-03       Impact factor: 6.118

8.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

Review 9.  Measurement of hemoglobin A(1c): a new twist on the path to harmony.

Authors:  David B Sacks
Journal:  Diabetes Care       Date:  2012-12       Impact factor: 19.112

10.  When the blood glucose and the HbA(1c) don't match: turning uncertainty into opportunity.

Authors:  Robert M Cohen; Christopher J Lindsell
Journal:  Diabetes Care       Date:  2012-12       Impact factor: 19.112

View more
  7 in total

1.  Implementation of HbA1c Point of Care Testing in 3 German Medical Practices: Impact on Workflow and Physician, Staff, and Patient Satisfaction.

Authors:  Karl-Heinz Patzer; Payam Ardjomand; Katharina Göhring; Guido Klempt; Andreas Patzelt; Markus Redzich; Mathias Zebrowski; Susanne Emmerich; Oliver Schnell
Journal:  J Diabetes Sci Technol       Date:  2018-03-13

2.  The effect of breastfeeding on postpartum fructosamine and HbA1c values after normal pregnancy.

Authors:  Cynthia Kearse; Michael P Carson; Maureen Kane; Rosemary Fitzgerald; Patricia Ragone; Lauren Plante
Journal:  Obstet Med       Date:  2019-10-22

3.  A longitudinal, observational study examining the relationships of patient satisfaction with services and mental well-being to their clinical course in young people with Type 1 diabetes mellitus during transition from child to adult health services.

Authors:  S Gray; T Cheetham; H McConachie; K D Mann; J R Parr; M S Pearce; A Colver
Journal:  Diabet Med       Date:  2018-05-31       Impact factor: 4.359

4.  Diabetes Prevention Education Program in a population with pre-diabetes in Nepal: a study protocol of a cluster randomised controlled trial (DiPEP).

Authors:  Pushpanjali Shakya; Archana Shrestha; Biraj Man Karmacharya; Abha Shrestha; Bård Eirik Kulseng; Eva Skovlund; Abhijit Sen
Journal:  BMJ Open       Date:  2021-11-24       Impact factor: 2.692

5.  Glycated haemoglobin (HbA1c) in mid-pregnancy and perinatal outcomes.

Authors:  Ellen Ø Carlsen; Quaker Harmon; Maria C Magnus; Helle M Meltzer; Iris Erlund; Lars C Stene; Siri E Håberg; Allen J Wilcox
Journal:  Int J Epidemiol       Date:  2022-06-13       Impact factor: 9.685

6.  Protocol: Developing a framework to improve glycaemic control among patients with type 2 diabetes mellitus in Kinshasa, Democratic Republic of the Congo.

Authors:  Jean-Pierre Fina Lubaki; Olufemi Babatunde Omole; Joel Msafiri Francis
Journal:  PLoS One       Date:  2022-09-26       Impact factor: 3.752

7.  Robust methods to correct for measurement error when evaluating a surrogate marker.

Authors:  Layla Parast; Tanya P Garcia; Ross L Prentice; Raymond J Carroll
Journal:  Biometrics       Date:  2020-10-16       Impact factor: 1.701

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.